Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1089 | 1042 | 1119 | 1194 | 1573 | 3933 |
Fund Return | 8.9% | 4.16% | 11.91% | 6.09% | 9.48% | 14.67% |
Place in category | 1043 | 1587 | 2526 | 756 | 760 | 38 |
% in Category | 34 | 52 | 86 | 33 | 46 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity Fund Feeder I EURi | 8.83B | 8.95 | 6.26 | 14.85 | ||
Fundsmith Equity Fund Feeder I EURe | 8.83B | 8.95 | 6.15 | 14.81 | ||
Fundsmith Equity Fund Feeder T EURt | 8.83B | 8.90 | 6.12 | 14.69 | ||
Fundsmith Equity Feeder Class R EUR | 8.83B | 8.72 | 5.58 | 14.12 | ||
Fundsmith Equity Feeder R EUR Inc | 8.83B | 8.72 | 5.59 | 14.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux N | 13.94B | 3.82 | 0.15 | - | ||
Capital Group New Perspective Funde | 13.94B | 4.41 | 1.82 | 10.03 | ||
Cap Group New Perspective lux C EUR | 13.94B | 4.59 | 2.37 | - | ||
Capital Group New Perspective Funbe | 13.94B | 4.06 | 0.81 | 8.96 | ||
Cap Group NewPerspective lux ZL EUR | 13.94B | 4.37 | 1.78 | 10.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.41 | 415.13 | +0.23% | |
Novo Nordisk B | DK0062498333 | 8.82 | 927.3 | +1.13% | |
L'Oreal | FR0000120321 | 7.06 | 452.10 | +1.66% | |
Meta Platforms | US30303M1027 | 5.75 | 466.83 | +0.05% | |
Stryker | US8636671013 | 5.44 | 341.09 | +0.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review